XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
AOCI
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   173,674,067      
Beginning balance at Dec. 31, 2021 $ 3,387,636 $ 1,738 $ 6,028,861 $ (1,443) $ (2,641,520)
Increase (Decrease) in Stockholders' Equity          
Exercise of common stock options (in shares)   706,134      
Stock Issued During Period, Value, Stock Options Exercised 6,524 $ 6 6,518    
Issuance of common stock to fund the Company's 401(k) match (in shares)   391,129      
Stock Issued During Period, Value, Employee Benefit Plan 29,202 $ 4 29,198    
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 0 $ 22 (22)    
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   2,220,510      
Stock-based compensation expense 206,823   206,823    
Proceeds from stock issued under the Company's stock purchase plan 25,491 $ 7 25,484    
Stock issued under the Company's stock purchase plan (in shares)   668,605      
Issuance of common stock to fund business combinations (in shares)   265,186      
Stock Issued During Period, Value, Acquisitions 14,792 $ 3 14,789    
Stockholders' Equity, Other (7)   (7)    
Net loss (623,506)       (623,506)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent (3,793)     (3,793)  
Ending balance (in shares) at Dec. 31, 2022   177,925,631      
Ending balance at Dec. 31, 2022 3,043,162 $ 1,780 6,311,644 (5,236) (3,265,026)
Increase (Decrease) in Stockholders' Equity          
Exercise of common stock options (in shares)   194,597      
Stock Issued During Period, Value, Stock Options Exercised 3,197 $ 2 3,195    
Issuance of common stock to fund the Company's 401(k) match (in shares)   517,550      
Stock Issued During Period, Value, Employee Benefit Plan 35,100 $ 5 35,095    
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 0 $ 18 (18)    
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   1,801,954      
Stock-based compensation expense 231,312   231,312    
Proceeds from stock issued under the Company's stock purchase plan 28,344 $ 10 28,334    
Stock issued under the Company's stock purchase plan (in shares)   924,448      
Stock Issued During Period, Value, Acquisitions 1,675   1,675    
Net loss (204,149)       (204,149)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent $ 6,664     6,664  
Ending balance (in shares) at Dec. 31, 2023 181,364,180 181,364,180      
Ending balance at Dec. 31, 2023 $ 3,145,305 $ 1,815 6,611,237 1,428 (3,469,175)
Increase (Decrease) in Stockholders' Equity          
Exercise of common stock options (in shares) 265,816 204,034      
Stock Issued During Period, Value, Stock Options Exercised $ 1,651 $ 2 1,649    
Issuance of common stock to fund the Company's 401(k) match (in shares)   617,384      
Stock Issued During Period, Value, Employee Benefit Plan 40,550 $ 6 40,544    
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (140) $ 25 (165)    
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   2,475,448      
Stock-based compensation expense 214,885   214,885    
Proceeds from stock issued under the Company's stock purchase plan 31,227 $ 9 31,218    
Stock issued under the Company's stock purchase plan (in shares)   955,392      
Net loss (1,028,857)       (1,028,857)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent $ (2,372)     (2,372)  
Ending balance (in shares) at Dec. 31, 2024 185,616,438 185,616,438      
Ending balance at Dec. 31, 2024 $ 2,402,249 $ 1,857 $ 6,899,368 $ (944) $ (4,498,032)